| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13461* | 2021 |
| Cross-laboratory analysis of brain cell type transcriptomes with applications to interpretation of bulk tissue data BO Mancarci, L Toker, SJ Tripathy, B Li, B Rocco, E Sibille, P Pavlidis eneuro 4 (6), 2017 | 156 | 2017 |
| Transcriptomic evidence for alterations in astrocytes and parvalbumin interneurons in subjects with bipolar disorder and schizophrenia L Toker, BO Mancarci, S Tripathy, P Pavlidis Biological psychiatry 84 (11), 787-796, 2018 | 114 | 2018 |
| Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain L Toker, GT Tran, J Sundaresan, OB Tysnes, G Alves, K Haugarvoll, ... Molecular neurodegeneration 16 (1), 1-20, 2021 | 82 | 2021 |
| Trehalose induced antidepressant-like effects and autophagy enhancement in mice NZ Kara, L Toker, G Agam, GW Anderson, RH Belmaker, H Einat Psychopharmacology 229, 367-375, 2013 | 75 | 2013 |
| Transcriptomic correlates of neuron electrophysiological diversity SJ Tripathy, L Toker, B Li, CL Crichlow, D Tebaykin, BO Mancarci, ... PLoS computational biology 13 (10), e1005814, 2017 | 61 | 2017 |
| A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population B Brakedal, L Toker, K Haugarvoll, C Tzoulis npj Parkinson's Disease 8 (1), 19, 2022 | 59 | 2022 |
| IP3 accumulation and/or inositol depletion: two downstream lithium’s effects that may mediate its behavioral and cellular changes Y Sade, L Toker, NZ Kara, H Einat, S Rapoport, D Moechars, GT Berry, ... Translational psychiatry 6 (12), e968-e968, 2016 | 59 | 2016 |
| Inositol-related gene knockouts mimic lithium’s effect on mitochondrial function L Toker, Y Bersudsky, I Plaschkes, V Chalifa-Caspi, GT Berry, ... Neuropsychopharmacology 39 (2), 319-328, 2014 | 57 | 2014 |
| Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition GS Nido, F Dick, L Toker, K Petersen, G Alves, OB Tysnes, I Jonassen, ... Acta neuropathologica communications 8, 1-14, 2020 | 49 | 2020 |
| Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channelopathies: a potential treatment target? GA Horvath, M Demos, C Shyr, A Matthews, L Zhang, S Race, ... Molecular genetics and metabolism 117 (1), 42-48, 2016 | 49 | 2016 |
| Whose sample is it anyway? Widespread misannotation of samples in transcriptomics studies [version 2; peer review L Toker, M Feng, P Pavlidis | 45* | 2016 |
| Mitochondrial dysfunction in psychiatric morbidity: current evidence and therapeutic prospects L Toker, G Agam Neuropsychiatric disease and treatment, 2441-2447, 2015 | 43 | 2015 |
| Assessing transcriptome quality in patch-seq datasets SJ Tripathy, L Toker, C Bomkamp, BO Mancarci, M Belmadani, P Pavlidis Frontiers in Molecular Neuroscience 11, 363, 2018 | 41 | 2018 |
| Lithium, inositol and mitochondria L Toker, G Agam ACS Chemical Neuroscience 5 (6), 411-412, 2014 | 28 | 2014 |
| Molecular effects of lithium are partially mimicked by inositol-monophosphatase (IMPA) 1 knockout mice in a brain region-dependent manner O Damri, Y Sade, L Toker, Y Bersudsky, RH Belmaker, G Agam, AN Azab European Neuropsychopharmacology 25 (3), 425-434, 2015 | 21 | 2015 |
| Gene-expression studies in understanding the mechanism of action of lithium L Toker, RH Belmaker, G Agam Expert review of neurotherapeutics 12 (1), 93-97, 2012 | 16 | 2012 |
| BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease Z Vitic, H Safory, VM Jovanovic, Y Sarusi, A Stavsky, J Kahn, A Kuzmina, ... Brain 144 (2), e15-e15, 2021 | 15 | 2021 |
| Chronic oral carbamazepine treatment elicits mood-stabilising effects in mice NZ Kara, O Karpel, L Toker, G Agam, RH Belmaker, H Einat Acta Neuropsychiatrica 26 (1), 29-34, 2014 | 15 | 2014 |
| Beware of your mouse strain; differential effects of lithium on behavioral and neurochemical phenotypes in Harlan ICR mice bred in Israel or the USA Y Sade, NZ Kara, L Toker, Y Bersudsky, H Einat, G Agam Pharmacology Biochemistry and Behavior 124, 36-39, 2014 | 14 | 2014 |
